联合123I-MIBG SPECT-CT影像组学与临床因素预测高危儿童神经母细胞瘤诱导缓解后无事件生存
回顾性纳入87例高危神经母细胞瘤患者并按7:3随机分为训练集和验证集,基于腰椎3-5椎体SPECT-CT影像组学特征联合临床因素构建列线图,训练集C-index为0.819、验证集为0.712,优于Curie评分和临床模型。
要点
- 基于腰椎3-5椎体SPECT-CT提取的11个影像组学特征构建模型,训练集C-index 0.780、验证集0.687。
- 联合影像组学与临床因素的列线图预测效能最佳,训练集C-index 0.819、验证集0.712。
- Curie评分评估无事件生存效能最低,训练集C-index 0.576、验证集0.553。
核心结论
- 基于123I-MIBG SPECT-CT的影像组学可准确预测高危神经母细胞瘤诱导缓解后的无事件生存。
- 构建的列线图可能实现个体化预后评估,并协助临床医生优化治疗和随访方案,从而可能改善患者生存。
研究设计与样本
- 回顾性研究,172例高危神经母细胞瘤患者接受123I-MIBG SPECT-CT检查,最终87例符合纳入排除标准。
- 87例按7:3比例随机分为训练集和验证集。
- 在SPECT-CT图像上勾画腰椎3-5椎体感兴趣区,提取并筛选影像组学特征构建影像组学模型。
- 采用单因素和多因素Cox回归分析确定临床危险因素并构建临床模型。
- 采用多因素Cox回归分析整合影像组学特征与临床危险因素构建列线图,以C-index和时间依赖ROC曲线评价模型效能。
诊断标准与关键数值
- Curie评分评估无事件生存的C-index训练集0.576、验证集0.553。
- 影像组学模型(基于11个影像组学特征)预测无事件生存的C-index训练集0.780、验证集0.687。
- 临床模型预测无事件生存的C-index训练集0.653、验证集0.667。
- 列线图预测无事件生存的C-index训练集0.819、验证集0.712,1年AUC训练集0.899、验证集0.748。
临床应用与阅片要点
- 可基于腰椎3-5椎体SPECT-CT影像组学特征联合临床因素构建列线图,用于高危神经母细胞瘤诱导缓解后无事件生存的个体化预测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Accurately quantifying event-free survival after induction of remission in high-risk neuroblastoma can lead to better subsequent treatment decisions, including whether more aggressive therapy or milder treatment is needed to reduce unnecessary treatment side effects, thereby improving patient survival.
OBJECTIVE: To develop and validate a 123I-metaiodobenzylguanidine (MIBG) single-photon emission computed tomography-computed tomography (SPECT-CT)-based radiomics nomogram and evaluate its value in predicting event-free survival after induction of remission in high-risk neuroblastoma.
MATERIALS AND METHODS: One hundred and seventy-two patients with high-risk neuroblastoma who underwent an 123I-MIBG SPECT-CT examination were retrospectively reviewed. Eighty-seven patients with high-risk neuroblastoma met the final inclusion and exclusion criteria and were randomized into training and validation cohorts in a 7:3 ratio. The SPECT-CT images of patients were visually analyzed to assess the Curie score. The 3D Slicer software tool was used to outline the region of interest of the lumbar 3-5 vertebral bodies on the SPECT-CT images. Radiomics features were extracted and screened, and a radiomics model was constructed with the selected radiomics features. Univariate and multivariate Cox regression analyses were used to determine clinical risk factors and construct the clinical model. The radiomics nomogram was constructed using multivariate Cox regression analysis by incorporating radiomics features and clinical risk factors. C-index and time-dependent receiver operating characteristic curves were used to evaluate the performance of the different models.
RESULTS: The Curie score had the lowest efficacy for the assessment of event-free survival, with a C-index of 0.576 and 0.553 in the training and validation cohorts, respectively. The radiomics model, constructed from 11 radiomics features, outperformed the clinical model in predicting event-free survival in both the training cohort (C-index, 0.780 vs. 0.653) and validation cohort (C-index, 0.687 vs. 0.667). The nomogram predicted the best prognosis for event-free survival in both the training and validation cohorts, with C-indices of 0.819 and 0.712, and 1-year areas under the curve of 0.899 and 0.748, respectively.
CONCLUSION: 123I-MIBG SPECT-CT-based radiomics can accurately predict the event-free survival of high-risk neuroblastoma after induction of remission The constructed nomogram may enable an individualized assessment of high-risk neuroblastoma prognosis and assist clinicians in optimizing patient treatment and follow-up plans, thereby potentially improving patient survival.
引用
- Feng L, Yang X, Wang C, et al. Predicting event-free survival after induction of remission in high-risk pediatric neuroblastoma: combining 123I-MIBG SPECT-CT radiomics and clinical factors. Pediatr Radiol. 2024. PMID: 38492045. doi:10.1007/s00247-024-05901-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。